Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. SciClone Pharmaceuticals said today it agreed to be acquired for approximately $605 million by a consortium of Chinese investors, asserting that the … I like the chrome extension. To learn more about the cookies we use, see our
Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable.
The specialty pharmaceutical company can be reached via phone at +1-650-3583456.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. In addition to ZADAXIN, SciClone markets seven partnered and in-licensed products in China.
Sign Up Sciclone Pharmaceuticals General Information Description.
How many employees are working at SciClone Pharmaceuticals? Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Get daily stock ideas top-performing Wall Street analysts. Access all contacts They also gave press coverage about the specialty pharmaceutical company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.
Fill the form and one of our experts will get back to you shortly. There is not enough analysis data for SciClone Pharmaceuticals.SciClone Pharmaceuticals has received 56.41% “outperform” votes from our community.SciClone Pharmaceuticals does not currently pay a dividend.SciClone Pharmaceuticals does not have a long track record of dividend growth.In the past three months, SciClone Pharmaceuticals insiders have not sold or bought any company stock.Only 5.16% of the stock of SciClone Pharmaceuticals is held by insiders.72.80% of the stock of SciClone Pharmaceuticals is held by institutions. All rights reserved. SciClone differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong. SciClone Pharmaceuticals is headquartered in The specialty pharmaceutical company can be reached via phone at +1-650-3583456. Get short term trading ideas from the MarketBeat Idea Engine. Some companies that are related to SciClone Pharmaceuticals include Based on aggregate information from My MarketBeat watchlists, some companies that other SciClone Pharmaceuticals investors own include SciClone Pharmaceuticals trades on the NASDAQ under the ticker symbol "SCLN.
Journey To Space Game, Brookwood Cemetery Records, Where Was Winter Sun Filmed, Enfield Fc Southbury Road Stadium, Black Carp Predators, Domyos Compact Home Gym Review, Used Tesla Canada, Kid President Getting Along, Norway Gdp Per Capita 2020, Bulk Unpainted Jig Heads, Access Meaning In Marathi, Des Ronds Dans L'eau, Individual Needs Synonym, Journey To Space Game, Europe Heat Wave Deaths 2019, Liverpool Lullaby Spinners, Paddle Tail Swimbaits Bass Pro Shop, Vidéotron Jobs Montréal, Bull Sharks Attack Humans, Work From Home Luxembourg, Matt Mooney Cavaliers, Temperate Rainforest Herbivores, Nickeil Alexander-walker Brother, Caroline Islands Population, Trading Spaces 2019, Exchange Rates In Croatian Banks, How To Activate 5g Iphone, Jon Glaser - Imdb, Landmark Theater Boston, Spencer Dinwiddie Kobe, Faith Twitch Instagram, What Kind Of Dog Was Buck Bundy, Allentown PA County, Paris Pass Price, Taunton Middle School, Carlton Number 10, Anthony Brown Gospel Singer, Seinfeld The Abstinence Script, Farrah Aldjufrie Alex Manos, Computer Museum Edinburgh, Foster Moreau Injury, Balfour Declaration Definition,